Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Marqibo in Relapsed/Refractory Ph- ALL
NCT00495079Phase 2Completed
- Sponsor
- Spectrum Pharmaceuticals, Inc.
- Start
- May 2007
- Primary completion
- Aug 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of vincristine sulfate liposome in acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), sponsored by Spectrum Pharmaceuticals, Inc.. Started May 2007; status: completed.
02
Drugs
vincristine sulfate liposome
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT00495079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00495079.